Nothing Special   »   [go: up one dir, main page]

PT1007067E - Composicoes farmaceuticas contendo partenio integrifolium ou partes dele ou um seu extracto ou componente o uso desse material vegetal para a preparacao de certos medicamentos e um processo para preparar um extracto de partenio integrifolium - Google Patents

Composicoes farmaceuticas contendo partenio integrifolium ou partes dele ou um seu extracto ou componente o uso desse material vegetal para a preparacao de certos medicamentos e um processo para preparar um extracto de partenio integrifolium

Info

Publication number
PT1007067E
PT1007067E PT97944746T PT97944746T PT1007067E PT 1007067 E PT1007067 E PT 1007067E PT 97944746 T PT97944746 T PT 97944746T PT 97944746 T PT97944746 T PT 97944746T PT 1007067 E PT1007067 E PT 1007067E
Authority
PT
Portugal
Prior art keywords
extract
integrifolium
preparation
parts
partentium
Prior art date
Application number
PT97944746T
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Eurovita A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurovita A S filed Critical Eurovita A S
Publication of PT1007067E publication Critical patent/PT1007067E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT97944746T 1996-10-21 1997-10-20 Composicoes farmaceuticas contendo partenio integrifolium ou partes dele ou um seu extracto ou componente o uso desse material vegetal para a preparacao de certos medicamentos e um processo para preparar um extracto de partenio integrifolium PT1007067E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK115896 1996-10-21
US3139596P 1996-11-19 1996-11-19

Publications (1)

Publication Number Publication Date
PT1007067E true PT1007067E (pt) 2002-07-31

Family

ID=26065310

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97944746T PT1007067E (pt) 1996-10-21 1997-10-20 Composicoes farmaceuticas contendo partenio integrifolium ou partes dele ou um seu extracto ou componente o uso desse material vegetal para a preparacao de certos medicamentos e um processo para preparar um extracto de partenio integrifolium

Country Status (10)

Country Link
US (1) US6217877B1 (pt)
EP (1) EP1007067B1 (pt)
JP (1) JP4346685B2 (pt)
AT (1) ATE211918T1 (pt)
AU (1) AU711019B2 (pt)
DE (1) DE69709691T2 (pt)
DK (1) DK1007067T3 (pt)
ES (1) ES2172006T3 (pt)
PT (1) PT1007067E (pt)
WO (1) WO1998017292A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277978B1 (en) 1995-12-22 2001-08-21 University Of Utah Research Foundation KVLQT1—a long QT syndrome gene
AU778538B2 (en) * 1999-03-10 2004-12-09 G.D. Searle & Co. Method and composition for administering a cyclooxygenase-2 inhibitor
US20010024664A1 (en) * 1999-03-19 2001-09-27 Obukowicz Mark G. Selective COX-2 inhibition from edible plant extracts
CO5190664A1 (es) 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
US8680081B2 (en) 2000-08-29 2014-03-25 Peter Van Patten Prophylactic treatment of migraine
WO2002047706A2 (en) * 2000-12-15 2002-06-20 Pharmacia Corporation Selective cox-2 inhibition from plant extracts
US7758582B2 (en) * 2002-06-14 2010-07-20 Smith & Nephew, Inc. Device and methods for placing external fixation elements
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
TWI344959B (en) * 2003-04-02 2011-07-11 Nat Health Research Institutes Treatment of hepatitis c virus infection with sesquiterpene lactones
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
ES2459742T3 (es) * 2004-12-22 2014-05-12 Ono Pharmaceutical Co., Ltd. Compuesto tricíclico y uso del mismo
EP2497459B1 (en) * 2005-03-10 2019-04-24 3M Innovative Properties Company Methods of reducing microbial contamination
EP1898900B1 (en) * 2005-03-10 2011-06-08 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxycarboxylic acids
JP2008533048A (ja) * 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 耳の感染症の治療方法
US7985734B2 (en) * 2006-06-01 2011-07-26 Yun Cheng Peptides for preventing or treating liver damage
CN104721602A (zh) * 2013-12-19 2015-06-24 汤丽娟 一种治疗腹型偏头痛的中药

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058594A (en) * 1974-04-25 1977-11-15 John Williams Immuno-suppressive agents
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
DE3638715A1 (de) * 1986-11-13 1988-05-26 Lohmann Rudolf Lomapharm Sesquiterpenverbindungen, verfahren zu ihrer isolierung und arzneimittel, enthaltend diese verbindungen
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
US5055297A (en) * 1987-03-27 1991-10-08 Tsumura Juntendo Immunopotentiator

Also Published As

Publication number Publication date
ES2172006T3 (es) 2002-09-16
WO1998017292A1 (en) 1998-04-30
ATE211918T1 (de) 2002-02-15
EP1007067A1 (en) 2000-06-14
DK1007067T3 (da) 2002-05-06
EP1007067B1 (en) 2002-01-16
AU711019B2 (en) 1999-10-07
DE69709691T2 (de) 2002-08-22
JP4346685B2 (ja) 2009-10-21
US6217877B1 (en) 2001-04-17
AU4615897A (en) 1998-05-15
DE69709691D1 (de) 2002-02-21
JP2001501919A (ja) 2001-02-13

Similar Documents

Publication Publication Date Title
PT1007067E (pt) Composicoes farmaceuticas contendo partenio integrifolium ou partes dele ou um seu extracto ou componente o uso desse material vegetal para a preparacao de certos medicamentos e um processo para preparar um extracto de partenio integrifolium
BR9702309A (pt) Uso composição cosmética ou farmacêutica e processo de tratamento cosmético
BR0108940A (pt) Composição herbal aprimorada que apresenta propriedades antialérgicas e processo de sua preparação
NZ336869A (en) Pharmaceutical compositions comprising aqueous alcoholic Centipeda plant extracts
GEP20002332B (en) Cefalosporin Derivatives
AU688650B2 (en) Cosmetic kaolin-containing preparation
HN2008000727A (es) Composiciones farmaceutica antimastitica de origen natural
BR9801736A (pt) Processo de produção de dextrano.
AU2383988A (en) Molecular decoyants and methods of use thereof
AU9699598A (en) Novel powder compositions
BR9815584A (pt) Composição cosmética, composição pressurizada em aerossol e processo de tratamento cosmético das matérias queratìnicas
DE60117606D1 (de) Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
AU8020698A (en) Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
DK1077725T3 (da) Topiske farmaceutiske sammensætninger til behandling af hudsygdomme eller kredslöbssygdomme på inflammatorisk, immun eller proliferativ eller degenerativ basis omfattende pollenekstrakt og uforsæbelig vegetabilsk olie
ES2013321A6 (es) Un metodo de produccion de anticuerpos monoclonales
EP0971722B1 (en) An aphrodisiac for application to the sexual organs
IT1199619B (it) Vernici additivate
ATE198258T1 (de) Gel-system enthaltend carrageen und kokonuss- endosperm
BR0102186A (pt) Uso de produto compreendendo extrato de catuama como agente antitromboembólico, composição farmacêutica compreendendo tal produto para tratamento ou prevenção de distúrbios tromboembólicos, método para tratamento de distúrbios tromboembólicos usando o referido produto e uso do referido produto para produção de uma composição farmacêutica para tratamento ou prevenção de distúrbios tromboembólicos
BR9901812A (pt) Adeviso com teor de sólidos muito elevado.
KR960006930A (ko) 키위를 이용한 인체면역성 증진 및 인체질환 치료방법
BR0103995A (pt) Solução amaciante e protetora para pele seca
SU1830659A1 (ru) Состав дератизационного покрытия
ES2170654A1 (es) Perfeccionamientos introducidos en el objeto de la patente p9900757, por un procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.